AirSculpt Technologies, Inc. Gains (Losses) on Restructuring of Debt
AirSculpt Technologies, Inc. (AIRS) reported Gains (Losses) on Restructuring of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnRestructuringOfDebt · last filed 2025-03-14
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for the quarter ending 2022-12-31 was -$932.00K.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for the quarter ending 2022-09-30 was $0.00.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for the quarter ending 2022-06-30 was $0.00.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for the quarter ending 2021-12-31 was $0.00.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for fiscal 2024 was $0.00.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for fiscal 2023 was $0.00.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for fiscal 2022 was -$932.00K.
- AirSculpt Technologies, Inc. gains (losses) on restructuring of debt for fiscal 2021 was -$682.00K.
| Period end | Gains (Losses) on Restructuring of Debt 3 month | Gains (Losses) on Restructuring of Debt 6 month | Gains (Losses) on Restructuring of Debt 9 month | Gains (Losses) on Restructuring of Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-14 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-14 | |||
| 2022-12-31 | -$932.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$932.00K derived: sum of 2 quarters · filed 2025-03-14 | -$932.00K derived: sum of 3 quarters · filed 2025-03-14 | -$932.00K 10-K · filed 2025-03-14 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | -$682.00K derived: sum of 3 quarters · filed 2024-02-27 | -$682.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | -$682.00K derived: sum of 2 quarters · filed 2022-11-14 | -$682.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$682.00K 10-Q · filed 2022-08-12 | -$682.00K 10-Q · filed 2022-08-12 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-03-10 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |